1Beaufort AM, Wierda JM, Belopavlovic M, et al. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anaesthesiol Suppl, 1995, 11:95-106.
2Aziz L,Ono K, Ohta Y. Effect of hypothermia on the in vitro potencies of neuromuscular blocking agents and on their antagonism by neostigmine.British Journal of Anaesthesia, 1994,73(5) :662-666.
3England A J, Wu X, Richards KM, et al. The influence of cold on the recovery of three neuromuscular blocking agents in man. Anaesthesia,1996,51 (3) :236-240.
4Smeulers NJ, Wierda JM, van den Broek L, et al. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium. J Cardiothorac Vasc Anesth, 1995,9(6):700-705.
5Ohnishi Y, Uchida O, Nakajima T,et al. Maintenance doses of vecuronium and pancuronium during hypothermic cardiopulmonary bypass. Masui,1993,42(7) :995-1001.
6Asokumar B, Cheng D, Chung F, et al. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.Can J Anaesth, 1998,45(6) :515-520.
7Heier T, Clough D, Wright PM, et al. The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers. Anesthesiology,2002,97( 1 ) :90-95.
8Ceelen WP, Hesse U, de Hemptinne B, et al. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg,2001,88( 1 ): 152.
9Kerner T, Deja M, Ahlers O, et al. Whole body hyperthermia: a secure procedure for patients with various malignancies.? Intensive Care Med,1999,25(9) :898-900.
10Meyer RE, Page RL,Thrall DE, et al. Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia. Cancer Research., 1986,46: 5599-5601.
